Carrier, M <br/><br/>
Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial.  [electronic resource] 

 -  The Journal of cardiovascular surgery  Apr 2008 
 - 249-53 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0021-9509 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aorta--physiology<br/>Cardiovascular Diseases--mortality<br/>Constriction<br/>Coronary Artery Bypass<br/>Creatine Kinase, MB Form--blood<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--etiology<br/>Myocardial Ischemia--etiology<br/>Purinergic P2 Receptor Antagonists<br/>Pyridoxal Phosphate--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Time Factors